GR3033622T3 - Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity - Google Patents

Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Info

Publication number
GR3033622T3
GR3033622T3 GR20000401308T GR20000401308T GR3033622T3 GR 3033622 T3 GR3033622 T3 GR 3033622T3 GR 20000401308 T GR20000401308 T GR 20000401308T GR 20000401308 T GR20000401308 T GR 20000401308T GR 3033622 T3 GR3033622 T3 GR 3033622T3
Authority
GR
Greece
Prior art keywords
erythromycin
antibiotic activity
oxime derivatives
derivatives endowed
endowed
Prior art date
Application number
GR20000401308T
Other languages
English (en)
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of GR3033622T3 publication Critical patent/GR3033622T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GR20000401308T 1994-12-13 2000-06-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity GR3033622T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (1)

Publication Number Publication Date
GR3033622T3 true GR3033622T3 (en) 2000-10-31

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401308T GR3033622T3 (en) 1994-12-13 2000-06-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Country Status (35)

Country Link
US (1) US5847092A (el)
EP (1) EP0797579B1 (el)
JP (1) JPH10510520A (el)
KR (1) KR100367559B1 (el)
CN (1) CN1046535C (el)
AP (1) AP739A (el)
AT (1) ATE190620T1 (el)
AU (1) AU690791B2 (el)
BG (1) BG63261B1 (el)
BR (1) BR9510015A (el)
CA (1) CA2207029A1 (el)
CZ (1) CZ289943B6 (el)
DE (1) DE69515694T2 (el)
DK (1) DK0797579T3 (el)
EE (1) EE03401B1 (el)
ES (1) ES2144154T3 (el)
FI (1) FI972493A (el)
GE (1) GEP20012391B (el)
GR (1) GR3033622T3 (el)
HU (1) HU220631B1 (el)
IT (1) IT1276901B1 (el)
LT (1) LT4276B (el)
LV (1) LV11898B (el)
MD (1) MD1788G2 (el)
NO (1) NO309816B1 (el)
NZ (1) NZ297446A (el)
OA (1) OA10491A (el)
PL (1) PL182053B1 (el)
PT (1) PT797579E (el)
RO (1) RO116282B1 (el)
RU (1) RU2152951C1 (el)
SI (1) SI9520124A (el)
TJ (1) TJ306B (el)
UA (1) UA48958C2 (el)
WO (1) WO1996018633A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) * 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
JP5383037B2 (ja) 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
DK90788A (da) 1987-02-24 1988-08-25 Beecham Group Plc Erythromycinderivater
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HU220631B1 (hu) 2002-03-28
FI972493A0 (fi) 1997-06-12
GEP20012391B (en) 2001-03-25
IT1276901B1 (it) 1997-11-03
MD1788F2 (en) 2001-11-30
MD1788G2 (ro) 2002-05-31
NZ297446A (en) 1999-06-29
AU690791B2 (en) 1998-04-30
EE03401B1 (et) 2001-04-16
FI972493A (fi) 1997-06-12
DE69515694D1 (de) 2000-04-20
ITMI942496A0 (it) 1994-12-13
HUT77126A (hu) 1998-03-02
US5847092A (en) 1998-12-08
EE9700124A (et) 1997-12-15
LT4276B (lt) 1998-01-26
EP0797579B1 (en) 2000-03-15
PT797579E (pt) 2000-08-31
ES2144154T3 (es) 2000-06-01
TJ306B (en) 2001-08-06
MD970243A (en) 1999-05-31
SI9520124A (sl) 1998-04-30
JPH10510520A (ja) 1998-10-13
CZ289943B6 (cs) 2002-04-17
CN1169727A (zh) 1998-01-07
RO116282B1 (ro) 2000-12-29
OA10491A (en) 2002-04-10
LV11898A (lv) 1997-12-20
RU2152951C1 (ru) 2000-07-20
KR100367559B1 (ko) 2003-04-21
BR9510015A (pt) 1997-10-28
PL182053B1 (pl) 2001-10-31
BG101570A (en) 1998-02-27
CA2207029A1 (en) 1996-06-20
WO1996018633A1 (en) 1996-06-20
AP9700989A0 (en) 1997-07-31
LT97116A (en) 1997-10-27
CN1046535C (zh) 1999-11-17
PL320688A1 (en) 1997-10-27
ITMI942496A1 (it) 1996-06-13
UA48958C2 (uk) 2002-09-16
LV11898B (en) 1998-03-20
NO972702L (no) 1997-08-13
CZ178697A3 (en) 1997-12-17
DK0797579T3 (da) 2000-06-05
ATE190620T1 (de) 2000-04-15
NO972702D0 (no) 1997-06-12
MX9704253A (es) 1997-09-30
DE69515694T2 (de) 2000-10-26
NO309816B1 (no) 2001-04-02
AU4260396A (en) 1996-07-03
BG63261B1 (bg) 2001-07-31
EP0797579A1 (en) 1997-10-01
AP739A (en) 1999-03-24

Similar Documents

Publication Publication Date Title
IL132767A0 (en) 9-Oxime erythromycin derivatives
HUP0001330A3 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
HUP0000198A3 (en) Erythromycin a derivatives
LT97116A (en) Erythromycin a 9-o-oxime derivatives endowed with antibiotic activity
ZA989835B (en) Erythromycin a derivatives
ZA989830B (en) Erythromycin a derivatives
AU6421398A (en) Erythromycin a derivatives
AU9646098A (en) Erythromycin a derivatives
AU5376394A (en) Erythromycin derivative
ZA981572B (en) Erythromycin a derivatives
IL115312A0 (en) Antibiotic macrolides
AU4222797A (en) Erythromycin a derivatives
AU4472797A (en) Erythromycin a derivatives
AU4472697A (en) Erythromycin a derivatives
EP0459525A3 (en) Genes encoding a 3-acylation enzyme for macrolide antibiotics
ZA916904B (en) Antibiotic ge1655 complex and its factors a,b,and c
SI1100806T1 (en) Erythromycin derivative with antibiotic activity
AU9645998A (en) Erythromycin a derivatives
IL115996A0 (en) Fluorenyl-hydroxamic derivatives endowed with immunosuppresive and anti-inflammatory activity
ZA951845B (en) Acid-stabile erythromycin derivatives
SI0966477T1 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees